Photodynamic therapy for skin rejuvenation: A pilotstudy using LED light and the substance 5-aminolevulinic acid

Phase 1

• Conditions: Photodamaged skin; MedDRA version: 19.1Level: PTClassification code 10068388Term: Actinic elastosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disorders; MedDRA version: 19.1Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disorders; Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]

• Registration Number: EUCTR2015-002537-22-AT
• Lead Sponsor: Medizinische Universität Wien, Univ. Klinik f. Dermatologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-12-23
• Last Update Posted: 12 February 2018

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 13

Inclusion Criteria

Patients between 40 and 80 with photodamaged skin and a photoaging
Score of 4 or more as well as skin type I-III
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 3

Exclusion Criteria

Known allergy to aminlevulinic acid
Patients with porphyria or taking photosensitizing drugs
Patients with severe compromised general state
Patients with other dermatological diseases in the treatment area
Patient with another skin rejuvenation treatment in the last 6 moths
Patients unable to stick to the study protocol
Pregnant or lactating women
Patients who are participating in another study

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified